3-D Matrix,Ltd. (7777)

Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Apr 30, 2025-0.9-100.54%
Apr 30, 2024164.7-184622.33%
Apr 30, 2023-0.1+33.45%
Apr 30, 2022-0.1+5.25%
Apr 30, 2021-0.1+55.36%
Apr 30, 2020-0-17.89%
Apr 30, 2019-0-27.16%
Apr 30, 2018-0.1-28.18%
Apr 30, 2017-0.1-168.38%
Apr 30, 20160.1-152.71%
Apr 30, 2015-0.3
AI Chat